Zinc: Role in the management of diarrhea and cholera

Diarrhea and cholera are major health problems. Vibrio cholera, the causative agent of cholera, infects the small intestine, resulting in vomiting, massive watery diarrhea and dehydration. Reduced water and electrolyte absorption is also due to zinc deficiency. Zinc has an important role in recovery from the disease. The combination of zinc with cholera vaccine and oral rehydration solutions has a positive impact on cholera and diarrhea. It has led to a decrease in the mortality and morbidity associated with diarrhea.     

Gastroenteritis in Children: Part II. Prevention and Management

The treatment of gastroenteritis in children focuses on preventing dehydration. A child with minimal or no dehydration should be encouraged to continue his or her usual diet plus drink adequate fluids. Many studies have shown that a child's regular diet reduces the duration of diarrhea. Oral rehydration therapy with a rehydration solution can be used to treat diarrhea in children with mild to moderate dehydration. Ondansetron can decrease vomiting or help avoid the need for intravenous fluid, but it increases episodes of diarrhea. Probiotics can be used to shorten the course of diarrhea. Good handwashing reduces the incidence of acute gastroenteritis, but not rotavirus. The introduction of two rotavirus vaccines in the United States in 2006 significantly reduced the incidence of rotavirus gastroenteritis. The oral, live vaccines have strong safety records, despite a minimal incidence of intussusception.     

An update on management of severe acute infectious gastroenteritis in children

This article focuses on clinical and diagnostic aspects relevant to severe acute infectious gastroenteritis in children and will update treatment strategies focused on, although not limited to, anti-infective therapy. For the purposes of this article we will consider severe acute infectious gastroenteritis as follows: watery diarrhea accompanied by, or at high risk for, moderate to severe dehydration due to abrupt onset of vomiting that reduces oral intake, and/or frequent emission of liquid stools, or moderate to severe dysenteric/bloody diarrhea with moderate to high-grade fever. The article will not include food poisoning associated with bacterial toxins and will only briefly discuss oral rehydration strategies and intravenous solutions. The article will also briefly discuss current preventive measures against rotavirus gastroenteritis through vaccination, a topic that has been extensively discussed elsewhere.     

A case of Jatropha multifida poisoning resembling organophosphate intoxication

Four siblings presented with vomiting, diarrhea and miosis following ingestion of the plant. This is the first report of miosis as a presenting sign of Jatropha intoxication. The combination of vomiting, diarrhea and miosis resembles the clinical presentation of organophosphate poisoning. This fact warrants the consideration of Jatropha ingestion in the differential diagnosis of organophosphate ingestion. Treatment of Jatropha intoxication is supportive with emphasis on rehydration. Measurement of plasma acetylcholinesterase activity levels, which is normal after Jatropha ingestion and decreased following organophosphate poisoning, may help differentiate between the two.     

Double-blind, randomized, controlled clinical trial of norfloxacin for cholera.

In a double-blind, randomized clinical trial with 78 adults with acute watery diarrhea and severe dehydration, 37 subjects were positive for Vibrio cholerae. In conjunction with rehydration therapy, 13 patients received norfloxacin, 12 received trimethoprim-sulfamethoxazole (TMP-SMX), and 12 received a placebo. Norfloxacin was superior to TMP-SMX and to the placebo in reducing stool output, duration of diarrhea, fluid requirements, and vibrio excretion. TMP-SMX was no better than the placebo.     

Pediatric viral gastroenteritis

Rotavirus and Norwalk agent cause most viral gastroenteritis in the pediatric population. Infection results in osmotic diarrhea, which can cause dehydration and acidosis. Oral rehydration therapy has been shown worldwide to be a safe and effective means of treating this disease. Formula feeding should be resumed as soon as possible; breast feeding should be maintained throughout the illness. Admission criteria are based on weight loss, serum sodium level and ability to rehydrate orally on an outpatient basis.     

Dehydration syndromes. Oral rehydration and fluid replacement

Dehydration caused by diarrhea remains a major source of morbidity and mortality worldwide. Dehydration is a common clinical presentation seen by most physicians. Clinical diagnosis depends on the recognition of signs and symptoms as well as change in weight. Laboratory studies are helpful in categorizing the dehydration as isotonic, hyponatremic, or hypernatremic, which is necessary to plan appropriate therapy. In many situations, oral rehydration therapy is possible and desirable. Intravenous rehydration remains the standard of care for children with severe dehydration and shock.     

Rotavirus gastroenteritis

Rotavirus is the single most important cause of severe, dehydrating gastroenteritis in infants and young children worldwide. Rotavirus gastroenteritis is associated with high morbidity in developed countries and significant mortality in developing countries. Virtually all children are infected with rotavirus by 3 years of age. Fecal-oral transmission is the most likely route of virus spread. Group A serotype strains G1 through G4 account for more than 90% of rotavirus gastroenteritis in humans, with G1 being the predominant serotype. The virus preferentially infects the mature small-intestinal enterocytes. Rotavirus gastroenteritis is characterized by fever, vomiting, and diarrhea, with vomiting particularly prominent. Dehydration is a frequent complication because of the severity of the diarrhea and the associated vomiting. Rehydration and maintenance of proper fluid and electrolyte balance remain the mainstay of treatment. Hygienic measures have little effect on the reduction of rotavirus infection rates. The disease can be effectively controlled by universal rotavirus vaccination.     

青褶伞中毒的物种鉴定、中毒特征及救治

目的 探索褶伞属青褶伞的物种鉴定,总结青褶伞中毒诊断及救治方法,为该蘑菇造成的中毒事件处理和中毒患者救治提供借鉴.方法 结合中毒案例,收集流行病学、临床诊断救治资料和可疑毒蘑菇样本,对毒蘑菇样本进行形态学和分子生物学鉴定,并对青褶伞造成的中毒特征及救治进行梳理.结果 2名中毒患者食用了不等量的,自行采集的白色野生蘑菇;发病潜伏期约4h.主要临床表现为恶心、呕吐、腹痛、腹泻(呈稀水样便),一名患者伴有谷丙转氨酶和谷草转氨酶的升高,另一名患者呕吐少量淡红色液体,并在第2天伴有淡血性稀水便.给予足量补液、激素、保肝、青霉素抗感染等对症支持治疗,3d后全部治愈出院.毒蘑菇样本通过形态学结合分子生物学方法鉴定为青褶伞(chlorophyllum molybdites).结论 该中毒事件是一起由青褶伞引起的经口中毒,青褶伞菌为有毒蘑菇,主要引起消化道刺激性改变,病情较轻,病程短;形态学结合分子生物学方法对青褶伞的物种鉴定是识别青褶伞的有效方法.     

Management of nausea, vomiting, and diarrhea during critical illness

Symptoms are subjective patient experiences that may negatively impact the patient's hospitalization, treatment plan, and quality of life. Critically ill patients frequently experience nausea, vomiting, and diarrhea related to underlying disease, procedures, and medical interventions (eg, medication, enteral feeding, surgery). Optimally, the nurse performs a subjective assessment that explores the patient's perception and impact of these symptoms to develop a comprehensive plan of care. Unfortunately, little evidence is available to guide assessment of nausea, vomiting, and diarrhea in critically ill nonverbal patients. Understanding the disease processes, medical treatments, and pathophysiology of these symptoms will assist the critical care nurse in the anticipation of symptoms and development of a proactive plan to alleviate the symptom-associated discomfort.     

Rotavirus infection

Rotavirus is one of the universal viruses that causes diarrhea(acute gastroenteritis) in the worldwide, and the infections are sporadically accompanied with critical illness. Ten percent of affected individuals are admitted to hospitals. The complications are commonly serious dehydration, several diseases of central nervous system, sepsis and postrenal insufficiency accompanied with renal stone. Two safety and effective vaccinations were implemented to prevent infections. According to the overseas guideline management for estimations for the severity and treatment by oral rehydration solution are recommended.     

Acute diarrhea in children. What to do and what not to do

Acute diarrhea is a leading cause of childhood morbidity and mortality. Primary care physicians and pediatricians should be familiar with its clinical features and management. Rehydration and maintenance of proper fluid and electrolyte balance are the most important aspects of treatment. While intravenous rehydration is the best form of treatment for children who are in shock or unable to drink, oral rehydration is the treatment of choice for the majority of children who have mild to moderate dehydration. Oral rehydration therapy is simple, practical, inexpensive, effective, and safe for children in developing as well as developed countries. We recommend the use of commercially available rather than homemade solutions. Antibiotic and antidiarrheal agents are usually not indicated. Early reintroduction of milk, formula, or solid food is important, as is instruction of parents in measures to minimize transmission of infectious agents.     

Refrigerated storage of lyophilized and rehydrated, lyophilized human red cells

Human red cells (RBCs) were collected in CPDA-1 and then freeze-dried in lyoprotective solution. The lyophilized RBCs were then stored at -20 degrees C for 7 days. At the end of the storage period, the lyophilized RBCs were rehydrated and washed in dextrose saline. The washed, reconstituted, lyophilized RBCs were resuspended in final wash solutions of ADSOL, CPDA-1, or a special additive solution containing glucose, citrate, phosphate, adenine, and mannitol, and then they were stored at 4 degrees C for an additional 7 days. The main purpose of this study was to determine whether human RBCs can be lyophilized in such a manner that normal metabolic, rheologic, and cellular properties are maintained during rehydration and subsequent storage in standard blood bank preservative solutions. Our results show that reconstituted, lyophilized RBCs maintained levels of ATP, 2,3 DPG, lactate, and cellular properties that are equal to or better than those in control nonlyophilized RBCs stored for a comparable period in CPDA-1. Reconstituted, lyophilized RBCs stored at 4 degrees C after rehydration also show better maintenance of ATP, 2,3 DPG, and lactate than do control RBCs stored in the same preservative solutions for comparable periods.     

Acute infectious diarrhea

Infectious diarrhea is both a local and a global concern. Illnesses can range from mild inconveniences to life-threatening epidemics. Although diarrhea can be caused by a vast array of pathogens, the cornerstone of prevention is provision of a safe food and water supply, application of basic hygiene principles, and the development and administration of vaccines. The cornerstone of treatment is rehydration. Selection of specific antimicrobial therapy should be based on disease presentation and epidemiologic factors.     

Preventing common enteral feeding complications in critically ill adult patients

Nutritional support provides critically ill patients with energy and nutrients required to face the demands of their illness and stress. For those unable to ingest orally, enteral feeding rather than parenteral feeding is recommended, as the former better preserves gut integrity, reduces risk of infection, and costs less. Early enteral feeding in critically ill patients is also associated with decreased disease severity, reduced complications, and shortened length of stay. Risks associated with enteral feeding include aspiration, diarrhea, vomiting, hyponatremia, and hyperglycemia. This article reviews current knowledge on enteral feeding and addresses correct feeding tube placement, proper feeding sites, assessing and managing gastric residual volume, and preventing feeding tube occultation. We also review information related to identifying and controlling risk factors for enteral feeding complications such as aspiration, diarrhea, vomiting, hyponatremia, and hyperglycemia. Nurses can use this information to provide high quality care for enteral feeding patients and develop institutional protocols, guidelines, and standards of care for such patients in intensive care units.     

Gastrointestinal insights during the COVID-19 epidemic

Coronavirus disease-2019 (COVID-19) has so far caused hundreds of mortalities worldwide. Although respiratory symptoms are the main complication in COVID-19 patients, the disease is also associated with gastrointestinal problems, with diarrhea, nausea, and vomiting being primary COVID-19 symptoms. Thus, cancer and inflammatory bowel disease (IBD) management, stool viral tests, and virus exposure are major concerns in the context of COVID-19 epidemic. In patients with colorectal cancer and IBD, the colonic mucosa exhibits elevated angiotensin-converting enzyme 2 receptor levels, enhancing COVID-19 susceptibility. In some cases, positive viral stool tests may be the only indicator of infection at admission or after leaving quarantine. Without supplemental stool tests, the risk of undetected COVID-19 transmission is high. Moreover, viral exposure during the regular or emergency endoscopic examination should be avoided. We carefully discuss key gastrointestinal concerns with regard to COVID-19 and call for more attention to such problems.     

Bacterial diseases of the colon

Acute diarrhea of bacterial origin is discussed for seven enteric pathogens, and specific antimicrobial therapy based on positive identification is stressed. Selection of patients with self-limited disease not requiring antimicrobial therapy is emphasized in order to avoid costly laboratory tests. The role of daycare facilities in the spread of enteric pathogens in this country is discussed. This article includes a review of newer methods for treating infants and children with oral rehydration and rapid refeeding.     

Diarrhea

Diarrhea is one manifestation of GI disturbance. Symptoms may be acute if caused by such things as infections, drug reactions, alterations in diet, heavy metal poisoning, or fecal impaction. Chronic diarrhea is a symptom of GI diseases such as irritable bowel syndrome, lactase deficiency, cancer of the colon, inflammatory bowel disease, and malabsorption diseases. Chronic diarrhea may also be associated with GI surgery, radiation therapy, laxative abuse, alcohol abuse, and chemotherapeutic agents. When interventions are required to deal with diarrhea, they may include such things as alteration in tube feeding products and methods of administration, fluid replacement by oral rehydration procedures, a rapid return to feeding, and education aimed at the health information clients need to prevent or control the symptom of diarrhea.